ARTICLE | Company News

Solasia, Lee’s Pharmaceutical Holdings Ltd. deal

December 7, 2015 8:00 AM UTC

Solasia granted Lee’s exclusive rights to commercialize Sancuso granisetron patch to treat chemotherapy-induced nausea and vomiting (CINV) in China, excluding Hong Kong and Macau. Solasia retains rights to promote the transdermal serotonin (5-HT3) receptor antagonist in Beijing, Shanghai and Guangzhou. ...